Ai-ris Yonekura Collier, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antibodies, Viral | 16 | 2024 | 3216 | 1.560 |
Why?
|
Placenta | 6 | 2023 | 1721 | 1.210 |
Why?
|
Antibodies, Neutralizing | 17 | 2024 | 2009 | 1.180 |
Why?
|
Pre-Eclampsia | 3 | 2023 | 1251 | 0.970 |
Why?
|
Milk, Human | 2 | 2021 | 490 | 0.680 |
Why?
|
Fetal Blood | 2 | 2021 | 1360 | 0.570 |
Why?
|
Vaccines, Synthetic | 5 | 2023 | 622 | 0.570 |
Why?
|
Maternal Mortality | 1 | 2019 | 307 | 0.540 |
Why?
|
Infant, Newborn, Diseases | 1 | 2022 | 587 | 0.530 |
Why?
|
Pregnancy | 19 | 2024 | 30175 | 0.510 |
Why?
|
Premature Birth | 3 | 2023 | 1814 | 0.480 |
Why?
|
Hypoglycemia | 1 | 2022 | 895 | 0.460 |
Why?
|
Complement Activation | 2 | 2021 | 447 | 0.440 |
Why?
|
T-Lymphocytes | 7 | 2022 | 10276 | 0.390 |
Why?
|
Diabetes, Gestational | 1 | 2022 | 1260 | 0.390 |
Why?
|
Cross Reactions | 3 | 2022 | 828 | 0.370 |
Why?
|
Immunity, Maternally-Acquired | 2 | 2020 | 112 | 0.340 |
Why?
|
Antibody Formation | 3 | 2024 | 1393 | 0.340 |
Why?
|
Pregnancy Complications, Infectious | 5 | 2021 | 2183 | 0.340 |
Why?
|
Immune Tolerance | 3 | 2021 | 2323 | 0.300 |
Why?
|
Immunization, Secondary | 3 | 2024 | 373 | 0.290 |
Why?
|
Antigen Presentation | 2 | 2010 | 1252 | 0.260 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 559 | 0.260 |
Why?
|
Lymph Nodes | 5 | 2011 | 3473 | 0.250 |
Why?
|
Immunity, Cellular | 2 | 2022 | 1560 | 0.240 |
Why?
|
Infectious Disease Transmission, Vertical | 3 | 2021 | 1360 | 0.240 |
Why?
|
Immunotherapy | 1 | 2021 | 4755 | 0.240 |
Why?
|
Stromal Cells | 4 | 2011 | 1337 | 0.220 |
Why?
|
Vaccines, Combined | 1 | 2023 | 70 | 0.210 |
Why?
|
Lactation | 2 | 2021 | 392 | 0.200 |
Why?
|
Fetal Weight | 1 | 2021 | 88 | 0.190 |
Why?
|
Immunity, Mucosal | 1 | 2024 | 498 | 0.180 |
Why?
|
Receptor, TIE-2 | 1 | 2021 | 182 | 0.180 |
Why?
|
Placentation | 1 | 2021 | 78 | 0.180 |
Why?
|
Protective Agents | 1 | 2021 | 150 | 0.180 |
Why?
|
Humans | 43 | 2024 | 768887 | 0.170 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2008 | 4651 | 0.170 |
Why?
|
Immunity, Humoral | 2 | 2022 | 610 | 0.160 |
Why?
|
Placenta Diseases | 1 | 2022 | 199 | 0.160 |
Why?
|
Immune Evasion | 1 | 2023 | 376 | 0.160 |
Why?
|
Female | 26 | 2024 | 397464 | 0.160 |
Why?
|
Receptors, Interleukin-15 | 1 | 2008 | 13 | 0.160 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 456 | 0.150 |
Why?
|
Immunoassay | 1 | 2021 | 746 | 0.140 |
Why?
|
Interleukin-10 | 1 | 2023 | 1184 | 0.140 |
Why?
|
Immunoglobulin G | 3 | 2024 | 4568 | 0.140 |
Why?
|
Infant, Newborn | 6 | 2023 | 26394 | 0.140 |
Why?
|
Immunomodulation | 1 | 2021 | 549 | 0.140 |
Why?
|
Fibrinogen | 1 | 2019 | 892 | 0.130 |
Why?
|
Postpartum Hemorrhage | 1 | 2019 | 273 | 0.130 |
Why?
|
Adaptive Immunity | 1 | 2021 | 733 | 0.130 |
Why?
|
Thrombocytopenia | 1 | 2023 | 1181 | 0.130 |
Why?
|
Epigenomics | 1 | 2020 | 961 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 1 | 2021 | 1855 | 0.110 |
Why?
|
Maternal Health Services | 1 | 2019 | 470 | 0.110 |
Why?
|
Pandemics | 3 | 2024 | 8745 | 0.110 |
Why?
|
RNA, Messenger | 3 | 2024 | 12809 | 0.110 |
Why?
|
Obstetrics | 1 | 2020 | 678 | 0.110 |
Why?
|
Maternal Exposure | 1 | 2020 | 1083 | 0.100 |
Why?
|
Infection Control | 1 | 2020 | 984 | 0.100 |
Why?
|
Prospective Studies | 6 | 2023 | 54950 | 0.100 |
Why?
|
Endothelium, Lymphatic | 1 | 2011 | 63 | 0.100 |
Why?
|
Vaccination | 4 | 2024 | 3436 | 0.090 |
Why?
|
Neutralization Tests | 2 | 2022 | 739 | 0.090 |
Why?
|
Endothelial Cells | 2 | 2021 | 3591 | 0.090 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2011 | 515 | 0.080 |
Why?
|
Infertility, Female | 1 | 2016 | 764 | 0.080 |
Why?
|
Physical Examination | 1 | 2016 | 1262 | 0.080 |
Why?
|
HELLP Syndrome | 1 | 2019 | 40 | 0.080 |
Why?
|
Thrombosis | 1 | 2023 | 2956 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2020 | 2783 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2023 | 3116 | 0.080 |
Why?
|
Adult | 12 | 2024 | 223818 | 0.080 |
Why?
|
Cytokines | 1 | 2023 | 7453 | 0.070 |
Why?
|
Trophoblasts | 1 | 2019 | 223 | 0.070 |
Why?
|
Blood Glucose | 1 | 2022 | 6434 | 0.070 |
Why?
|
Cohort Studies | 5 | 2022 | 41800 | 0.070 |
Why?
|
Infant | 4 | 2022 | 36541 | 0.070 |
Why?
|
Immunoglobulin M | 2 | 2022 | 1528 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3811 | 0.070 |
Why?
|
Autoantigens | 2 | 2010 | 891 | 0.070 |
Why?
|
Self Tolerance | 1 | 2006 | 122 | 0.070 |
Why?
|
Case-Control Studies | 4 | 2022 | 22294 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2021 | 18366 | 0.060 |
Why?
|
Life Style | 1 | 2016 | 3931 | 0.060 |
Why?
|
Antigens | 1 | 2009 | 1444 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3421 | 0.060 |
Why?
|
Thymus Gland | 1 | 2008 | 1266 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 3109 | 0.050 |
Why?
|
Pancreas | 1 | 2009 | 1700 | 0.050 |
Why?
|
Compassionate Use Trials | 1 | 2021 | 50 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26384 | 0.050 |
Why?
|
Sulfonic Acids | 1 | 2021 | 102 | 0.050 |
Why?
|
Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.050 |
Why?
|
Animals | 8 | 2024 | 169408 | 0.050 |
Why?
|
Pregnancy, Multiple | 1 | 2022 | 216 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 2024 | 992 | 0.050 |
Why?
|
Young Adult | 3 | 2024 | 60110 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2022 | 81892 | 0.050 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 185 | 0.040 |
Why?
|
Adenosine Monophosphate | 1 | 2021 | 232 | 0.040 |
Why?
|
Immunization | 1 | 2024 | 1219 | 0.040 |
Why?
|
Melanoma | 1 | 2008 | 5709 | 0.040 |
Why?
|
Alanine | 1 | 2021 | 614 | 0.040 |
Why?
|
Nitric Oxide | 2 | 2022 | 2149 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 644 | 0.040 |
Why?
|
Amino Acids | 1 | 2024 | 1716 | 0.040 |
Why?
|
Intestines | 1 | 2006 | 1911 | 0.040 |
Why?
|
Fetal Growth Retardation | 1 | 2021 | 590 | 0.040 |
Why?
|
Insulinoma | 1 | 2008 | 122 | 0.040 |
Why?
|
Syndrome | 1 | 2023 | 3274 | 0.040 |
Why?
|
Influenza A virus | 1 | 2020 | 460 | 0.030 |
Why?
|
Models, Organizational | 1 | 2020 | 548 | 0.030 |
Why?
|
Mice, Transgenic | 3 | 2011 | 9564 | 0.030 |
Why?
|
Oocytes | 1 | 2022 | 1172 | 0.030 |
Why?
|
Pregnant Women | 1 | 2021 | 571 | 0.030 |
Why?
|
United States | 3 | 2020 | 73180 | 0.030 |
Why?
|
Fetal Development | 1 | 2021 | 771 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2021 | 1094 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1027 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2009 | 5803 | 0.030 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2009 | 3447 | 0.030 |
Why?
|
Gene Expression | 2 | 2021 | 7602 | 0.030 |
Why?
|
Fertilization in Vitro | 1 | 2022 | 1302 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2021 | 1767 | 0.030 |
Why?
|
Birth Weight | 1 | 2021 | 2108 | 0.030 |
Why?
|
Vascular Diseases | 1 | 2021 | 1162 | 0.030 |
Why?
|
Middle Aged | 3 | 2024 | 223740 | 0.030 |
Why?
|
Infant, Premature | 1 | 2022 | 2121 | 0.030 |
Why?
|
Gestational Age | 1 | 2021 | 3610 | 0.030 |
Why?
|
RNA, Viral | 1 | 2020 | 2871 | 0.020 |
Why?
|
ROC Curve | 1 | 2019 | 3629 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2452 | 0.020 |
Why?
|
Boston | 1 | 2024 | 9375 | 0.020 |
Why?
|
Viral Load | 1 | 2020 | 3398 | 0.020 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2016 | 503 | 0.020 |
Why?
|
Intercellular Junctions | 1 | 2011 | 198 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2011 | 22381 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2011 | 381 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2957 | 0.020 |
Why?
|
Oxygen | 1 | 2022 | 4273 | 0.020 |
Why?
|
Inflammation | 1 | 2010 | 10869 | 0.020 |
Why?
|
Mice, Knockout | 3 | 2011 | 14485 | 0.020 |
Why?
|
Poly I-C | 1 | 2010 | 111 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 2011 | 5505 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3913 | 0.020 |
Why?
|
Toll-Like Receptor 3 | 1 | 2010 | 99 | 0.020 |
Why?
|
Patient Care Team | 1 | 2020 | 2527 | 0.020 |
Why?
|
Neoplasms | 1 | 2008 | 22390 | 0.020 |
Why?
|
Male | 6 | 2024 | 365249 | 0.020 |
Why?
|
Ovalbumin | 1 | 2010 | 677 | 0.020 |
Why?
|
Transgenes | 1 | 2011 | 1016 | 0.020 |
Why?
|
Mice | 5 | 2011 | 82074 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 59738 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2010 | 1866 | 0.020 |
Why?
|
Quality Improvement | 1 | 2020 | 3856 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2009 | 1839 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2009 | 1714 | 0.010 |
Why?
|
Alternative Splicing | 1 | 2009 | 1105 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2010 | 1363 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 21545 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2011 | 3163 | 0.010 |
Why?
|
Lung | 1 | 2021 | 10097 | 0.010 |
Why?
|
Cell Proliferation | 2 | 2010 | 10486 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15955 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 17174 | 0.010 |
Why?
|
Mice, Inbred BALB C | 1 | 2009 | 6232 | 0.010 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5443 | 0.010 |
Why?
|
Aged | 2 | 2024 | 171790 | 0.010 |
Why?
|
Gene Expression Regulation | 2 | 2009 | 11934 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4356 | 0.010 |
Why?
|
Cell Movement | 1 | 2011 | 5216 | 0.010 |
Why?
|
Antigens, CD | 1 | 2010 | 4032 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2010 | 3714 | 0.010 |
Why?
|
Base Sequence | 1 | 2009 | 12430 | 0.010 |
Why?
|
Signal Transduction | 1 | 2021 | 23652 | 0.010 |
Why?
|
Peptides | 1 | 2010 | 4353 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 17629 | 0.010 |
Why?
|
Child | 1 | 2024 | 80969 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 89247 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2011 | 19023 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2006 | 3047 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2006 | 2748 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2009 | 9618 | 0.010 |
Why?
|
Transcription Factors | 1 | 2009 | 12174 | 0.010 |
Why?
|